Gilead Sciences
GILD
#125
Rank
C$212.28 B
Marketcap
C$171.08
Share price
-1.90%
Change (1 day)
35.74%
Change (1 year)

Gilead Sciences (GILD) - Total debt

Total debt on the balance sheet as of September 2025 : C$34.79 Billion

According to Gilead Sciences's latest financial reports the company's total debt is C$34.79 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Gilead Sciences - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31C$38.32 B15.65%
2023-12-31C$33.14 B-3.2%
2022-12-31C$34.23 B0.63%
2021-12-31C$34.02 B-15.03%
2020-12-31C$40.03 B24.66%
2019-12-31C$32.11 B-13.7%
2018-12-31C$37.21 B-11.74%
2017-12-31C$42.17 B19.11%
2016-12-31C$35.40 B15.72%
2015-12-31C$30.59 B112.54%
2014-12-31C$14.39 B103.77%
2013-12-31C$7.06 B-13.62%
2012-12-31C$8.17 B5.68%
2011-12-31C$7.73 B122.14%
2010-12-31C$3.48 B165.19%
2009-12-31C$1.31 B-6.89%
2008-12-31C$1.41 B7.79%
2007-12-31C$1.30 B-20.31%
2006-12-31C$1.64 B368.88%
2005-12-31C$0.35 B70171.25%
2004-12-31C$0.49 M-99.89%
2003-12-31C$0.44 B-52.35%
2002-12-31C$0.94 B134.38%
2001-12-31C$0.40 B4.92%
2000-12-31C$0.38 B201.41%
1999-12-31C$0.12 B-18.69%
1998-12-31C$0.15 B3313.18%
1997-12-31C$4.57 M-48.65%
1996-12-31C$8.9 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Amgen
AMGN
C$76.16 B 118.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$2.55 B-92.64%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$95.91 B 175.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$3.59 B-89.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$9.19 B-73.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$84.89 B 143.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$63.89 B 83.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$59.30 B 70.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$57.72 B 65.89%๐Ÿ‡บ๐Ÿ‡ธ USA